Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1716 ARTÍCULOS , VIENDO DEL 1411 AL 1425

Tubulin modifying enzymes as target for the treatment of tau-related diseases

Rogowski K, Hached K, Crozet C, van der Laan S.

Pharmacol Ther. 2021 Feb;218:107681. doi: 10.1016/j.pharmthera.2020.107681. Epub 2020 Sep 19.

Microbiota modulation as preventative and therapeutic approach in Alzheimer's disease

Bonfili L, Cecarini V, Gogoi O, Gong C, Cuccioloni M, Angeletti M, Rossi G, Eleuteri AM.

FEBS J. 2021 May;288(9):2836-2855. doi: 10.1111/febs.15571. Epub 2020 Oct 8.

Insulin resistance: a connecting link between Alzheimer's disease and metabolic disorder

Kshirsagar V, Thingore C, Juvekar A.

Metab Brain Dis. 2021 Jan;36(1):67-83. doi: 10.1007/s11011-020-00622-2. Epub 2020 Sep 28.

One call makes a difference: An evaluation of the Alzheimer's Association National Helpline on dementia caregiver outcomes

Hodgson NA, Petrovsky DV, Finegan K, Kallmyer BA, Pike J, Fazio S.

Patient Educ Couns. 2021 Apr;104(4):896-902. doi: 10.1016/j.pec.2020.09.026. Epub 2020 Sep 23.

Small-molecule BACE1 inhibitors: a patent literature review (2011 to 2020)

Rombouts F, Kusakabe KI, Hsiao CC, Gijsen HJM.

Expert Opin Ther Pat. 2021 Jan;31(1):25-52. doi: 10.1080/13543776.2021.1832463. Epub 2020 Dec 17.

From bedside to battlefield: intersection of ketone body mechanisms in geroscience with military resilience

Stubbs BJ, Koutnik AP, Volek JS, Newman JC.

Geroscience. 2021 Jun;43(3):1071-1081. doi: 10.1007/s11357-020-00277-y. Epub 2020 Oct 2.

Leading the way in the nervous system: Lipid Droplets as new players in health and disease

Teixeira V, Maciel P, Costa V.

Biochim Biophys Acta Mol Cell Biol Lipids. 2021 Jan;1866(1):158820. doi: 10.1016/j.bbalip.2020.158820. Epub 2020 Oct 1.

Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease

Marucci G, Buccioni M, Ben DD, Lambertucci C, Volpini R, Amenta F.

Neuropharmacology. 2021 Jun 1;190:108352. doi: 10.1016/j.neuropharm.2020.108352. Epub 2020 Oct 6.

Sigma ligands as potent inhibitors of Aβ and AβOs in neurons and promising therapeutic agents of Alzheimer's disease

Ma WH, Chen AF, Xie XY, Huang YS.

Neuropharmacology. 2021 Jun 1;190:108342. doi: 10.1016/j.neuropharm.2020.108342. Epub 2020 Oct 9.

Comparative study of the volume of the temporal lobe sections and neuropeptide effect in Alzheimer's patients and healthy persons

Petekkaya E, Burakgazi G, Kuş B, Melek İM, Arpacı A.

Int J Neurosci. 2021 Aug;131(8):725-734. doi: 10.1080/00207454.2020.1831490. Epub 2020 Oct 16.

Dissecting Alzheimer's disease pathogenesis in human 2D and 3D models

Cenini G, Hebisch M, Iefremova V, Flitsch LJ, Breitkreuz Y, Tanzi RE, Kim DY, Peitz M, Brüstle O.

Mol Cell Neurosci. 2021 Jan;110:103568. doi: 10.1016/j.mcn.2020.103568. Epub 2020 Oct 14.

Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer's disease

Arnsten AFT, Datta D, Del Tredici K, Braak H.

Alzheimers Dement. 2021 Jan;17(1):115-124. doi: 10.1002/alz.12192. Epub 2020 Oct 19.

The structure and phase of tau: from monomer to amyloid filament

Zeng Y, Yang J, Zhang B, Gao M, Su Z, Huang Y.

Cell Mol Life Sci. 2021 Mar;78(5):1873-1886. doi: 10.1007/s00018-020-03681-x. Epub 2020 Oct 19.

Neurobiochemical Cross-talk Between COVID-19 and Alzheimer's Disease

Rahman MA, Islam K, Rahman S, Alamin M.

Mol Neurobiol. 2021 Mar;58(3):1017-1023. doi: 10.1007/s12035-020-02177-w. Epub 2020 Oct 19.

Physical exercise protocols in animal models of Alzheimer's disease: a systematic review

De Sousa RAL, Rodrigues CM, Mendes BF, Improta-Caria AC, Peixoto MFD, Cassilhas RC.

Metab Brain Dis. 2021 Jan;36(1):85-95. doi: 10.1007/s11011-020-00633-z. Epub 2020 Oct 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias